INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Systematic review / meta-analysis / 2003

Ephedrine and ephedra modestly increase short-term weight loss but increase adverse symptoms

A meta-analysis of 52 controlled trials assessed ephedra and ephedrine for weight loss. Compared to placebo, monthly weight loss was greater with ephedrine (0.6 kg; 95% CI, 0.2-1.0), ephedrine with caffeine (1.0 kg; 95% CI, 0.7-1.3), ephedra (0.8 kg; 95% CI, 0.4-1.2), and ephedra with caffeine herbs (1.0 kg; 95% CI, 0.6-1.3). Ephedra or ephedrine use was linked to 2.2- to 3.6-fold higher odds of psychiatric, autonomic, or gastrointestinal symptoms, and heart palpitations.

Study type
Systematic review and meta-analysis of controlled trials
Who was studied
52 controlled trials and adverse event reports
What was measured
Weight loss, athletic performance, and adverse events

THE PAPER

Efficacy and safety of ephedra and ephedrine for weight loss and athletic performance: a meta-analysis.

Shekelle PG, Hardy ML, Morton SC, Maglione M, Mojica WA, Suttorp MJ, Rhodes SL, Jungvig L, Gagné J. JAMA, 2003.

PubMed 12672771 ↗DOI 10.1001/jama.289.12.1537 ↗

Weight & appetite

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.